Watanabe et al. Analytical Biochem. 195, 38-44, 1991.* |
International Search Report from the European Patent Office (International Search Authority) for PCT/US01/28828 (counterpart PCT application). |
Lauffenburger et al., “Scratching the (cell) surface: cytokine engineering for improved ligand/receptor trafficking dynamics”, Chem Biol 5:R257-R263, 1998. |
French and Lauffenburger, “Controlling Receptor/Ligand Trafficking: Effects of Cellular and Molecular Properties on Endosomal Sorting”, Ann Biomed Eng 25:690-707, 1997. |
Vecchiarelli et al., “Beneficial Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on Fungicidal Activity of Polymorphonuclear Leukocytes from Patients with AIDS”, J Infect Dis 171: 1448-1454, 1995. |
Fukunaga et al., “Growth and Differentiation Signals Mediated by Different Regions in the Cytoplasmic Domain of Granulocyte Colony-Stimulating Factor Receptor”, Cell 74:1079-1087, 1993. |
Welte et al., “Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor”, Proc Natl Acad Sci USA 82:1526-1530, 1985. |
Souza et al., “Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells”, Science 232:61-65, 1986. |
Gabrilove, “Introduction and Overview of Hematopoietic Growth Factors”, Sem Hematol 26(2):1-14, 1989. |
Wendel et al., “Granulocyte Colony-Stimulating Factor Treatment Protects Rodents Against Lipopolysaccharide-Induced Toxicity Via Suppression of Systemic Tumor Necrosis Factor”, J Immunol 149:918-924, 1992. |
Horan et al., “Dimerization of the Extracellular Domain of Granulocyte-Colony Stimulating Factor Receptor by Ligand Binding: A Monovalent Ligand Induced 2:2 Complexes”, Biochemistry 35:4886-4896, 1996. |
Horan et al., “Dimerization of Granulocyte-Colony Stimulating Factor Receptor: The lg Plus CRH Construct of Granulocyte-Colony Stimulating Factor Receptor Forms a 2:2 Complex with a Ligand”, J Biochem 121:370-375, 1997. |
Fukunaga et al., “Functional domains of the granuloctye colony-stimulating factor receptor”, EMBO J 10:2855-2865, 1991. |
Aritomi et al., Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme, Nature 401:713-717, 1999. |
Jones et al., “Growth factors in haemopoiesis”, Bailliere's Clin Hematol 2(1):83-111, 1989. |
Nagata et al., “The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor”, EMBO J 5:575-581, 1986. |
Moore et al., “Synergy of interleukin 1 and granulocyte colony-stimulating factor: In Vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice”, Proc Natl Acad Sci USA 84:7134-7138, 1987. |
Diflo et al., “ASSLD Abstract of Papers”, Hepatology 16:PA278, 1992. |
Wright et al., “Abstracts of Papers Submitted to the American Association for the Study of Liver Diseases”, Hepatology 14:PA48, 1991. |
Lachaux et al., “Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type lb”, J Ped 123:1005-1008, 1993. |
Colquehoun et al., “Reversal of Neutropenia with Granulocyte Colony-Stimulating Factor Without Precipitating Liver Allograft Rejection”, Transplantation 56:755-758, 1993. |
Kuga et al., “Mutagenesis of human granulocyte colony stimulating factor”, Biochem Biophys Res Comm 159:103-111, 1989. |
Lu et al., Disulfide and Secondary Structures of Recombinant Human Granulocyte Colony Stimulating Factor, Arch Biochem Biophys 268:81-92, 1989. |
Okabe et al., “In Vitro and In Vivo Hematopoietic Effect of Mutant Human Granulocyte Colony-Stimulating Factor”, Blood 75(9):1788-1793, 1990. |
Kuwubara et al., “Receptor-mediated clearance of G-CSF derivative nartograstim in bone marrow of rats”, Amer J Physiol Endocrinol Metabol 32:E1-E9, 1995. |
Wiley et al., “The Endocytotic Rate Constant: A Cellular Parameter for Quantitating Receptor-Mediated Endocytosis”, J Biol Chem 257:4222-4229, 1982. |